pubmed.ncbi.nlm.nih.gov

Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control - PubMed

Comparative Study

Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control

Daniel M Mueller et al. Atherosclerosis. 2015 Dec.

Abstract

Background: After ingestion of phosphatidylcholine, l-carnitine or betaine, trimethylamine-N-oxide (TMAO) is formed by gut microbiota and liver enzymes. Elevated TMAO plasma levels were associated with increased cardiovascular risk and other diseases. Also betaine and choline itself were recently associated with increased cardiovascular risk.

Methods: A newly developed LC-HRMS method was applied to measure the plasma concentrations of TMAO, betaine and choline in a cohort of 339 patients undergoing coronary angiography for the evaluation of suspected coronary artery disease.

Results: Betaine concentrations in males were significantly higher than in females (42.0 vs. 35.9 μmol/L; p < 0.001). Plasma concentrations of TMAO but not of betaine or choline were higher in patients with diabetes compared to euglycemic patients (2.39 vs. 0.980 μmol/L; p = 0.001) as well as in patients with metabolic syndrome as compared to patients without metabolic syndrome (2.37 vs. 1.43 μmol/L; p = 0.002). Plasma concentrations of TMAO or choline increased significantly with decreasing renal function (Spearman's rho: -0.281; p < 0.001). However, plasma levels of TMAO or betaine were associated with neither a history of myocardial infarction nor the angiographically assessed presence of coronary heart disease, nor incident cardiovascular events during 8 years of follow-up. Plasma levels of choline were significantly lower in patients with a history of acute myocardial infarction as compared to those without such history (10.0 vs. 10.8 μmol/L; p = 0.045).

Conclusions: Plasma levels of TMAO are confounded by impaired kidney function and poor metabolic control but are not associated with the history, presence or incidence of symptoms or events of coronary heart disease.

Keywords: Betaine; Cardiovascular risk; Choline; Kidney function; Metabolic control; TMAO.

PubMed Disclaimer

Cited by

Causality of small and large intestinal microbiota in weight regulation and insulin resistance.
Scheithauer TP, Dallinga-Thie GM, de Vos WM, Nieuwdorp M, van Raalte DH. Scheithauer TP, et al. Mol Metab. 2016 Jun 10;5(9):759-70. doi: 10.1016/j.molmet.2016.06.002. eCollection 2016 Sep. Mol Metab. 2016. PMID: 27617199 Free PMC article.
Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation.
Tousoulis D, Guzik T, Padro T, Duncker DJ, De Luca G, Eringa E, Vavlukis M, Antonopoulos AS, Katsimichas T, Cenko E, Djordjevic-Dikic A, Fleming I, Manfrini O, Trifunovic D, Antoniades C, Crea F. Tousoulis D, et al. Cardiovasc Res. 2022 Dec 29;118(16):3171-3182. doi: 10.1093/cvr/cvac057. Cardiovasc Res. 2022. PMID: 35420126 Free PMC article. Review.
The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy.
Xiong X, Zhou J, Fu Q, Xu X, Wei S, Yang S, Chen B. Xiong X, et al. Lipids Health Dis. 2022 Jul 21;21(1):60. doi: 10.1186/s12944-022-01673-3. Lipids Health Dis. 2022. PMID: 35864500 Free PMC article.
Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
Dong C, Yang Y, Wang Y, Hu X, Wang Q, Gao F, Sun S, Liu Q, Li L, Liu J, Tang Y, Zhang S, Wu C, Zhu H. Dong C, et al. J Adv Res. 2023 Apr;46:101-112. doi: 10.1016/j.jare.2022.06.008. Epub 2022 Jun 21. J Adv Res. 2023. PMID: 35750287 Free PMC article.
Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
Tang WHW, Li XS, Wu Y, Wang Z, Khaw KT, Wareham NJ, Nieuwdorp M, Boekholdt SM, Hazen SL. Tang WHW, et al. Am Heart J. 2021 Jun;236:80-86. doi: 10.1016/j.ahj.2021.01.020. Epub 2021 Feb 21. Am Heart J. 2021. PMID: 33626384 Free PMC article.

Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control - PubMed